electroCore (ECOR) Liabilities and Shareholders Equity (2017 - 2026)
electroCore (ECOR) posted quarterly Liabilities and Shareholders Equity of $15.5 million for Q1 2026, down 3.48% year-over-year from $16.0 million in Q1 2025, and down 17.06% quarter-over-quarter from $18.7 million in Q4 2025.
electroCore (ECOR) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
electroCore's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $15.5 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 3.48% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $70.1 million (down 12.25% YoY), while the FY2025 annual figure was $18.7 million, down 8.81% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $15.5 million, down from $18.7 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $37.2 million in Q1 2022, with the low at $13.9 million in Q1 2024.
- The 5-year median for Liabilities and Shareholders Equity is $20.1 million (2023), against an average of $21.0 million.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity slumped 57.52% in 2023, then jumped 57.19% in 2024.
- electroCore's Liabilities and Shareholders Equity stood at $24.8 million in 2022, then plunged by 34.96% to $16.1 million in 2023, then advanced by 27.13% to $20.5 million in 2024, then fell by 8.81% to $18.7 million in 2025, then declined by 17.06% to $15.5 million in 2026.
- Business Quant data shows ECOR's Liabilities and Shareholders Equity at $15.5 million in Q1 2026, $18.7 million in Q4 2025, and $21.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 10.74 Bn |
| 10 | electroCore | 94.04 Mn | 84.00 Mn | 8.18 Mn | 17.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.06 Mn |
| Mar 31, 2026 | 15.48 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 21.41 Mn |
| Jun 30, 2025 | 14.56 Mn |
| Mar 31, 2025 | 16.04 Mn |
| Dec 31, 2024 | 20.47 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Jun 30, 2024 | 22.36 Mn |
| Mar 31, 2024 | 13.89 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 14.22 Mn |
| Mar 31, 2023 | 18.30 Mn |
| Dec 31, 2022 | 24.76 Mn |
| Sep 30, 2022 | 29.49 Mn |
| Jun 30, 2022 | 33.48 Mn |
| Mar 31, 2022 | 37.18 Mn |
| Dec 31, 2021 | 42.83 Mn |
| Sep 30, 2021 | 47.57 Mn |